Lung cancer drug shows big promise in early tests
Doctors are reporting unusually high success rates from early tests of an experimental lung cancer drug.
Chicago: Doctors are reporting unusually high success rates from early tests of an experimental lung cancer drug.
The drug, called crizotinib, is made by Pfizer Inc. It targets a gene that is found in about 4 percent of lung cancers, which amounts to 10,000 people a year in the United States alone.
In a study of 82 patients with advanced lung cancer, more than 90 percent saw their tumors shrink after two months on the drug.
Much more testing is needed to see if the drug is safe and effective. Researchers have already started a large study to test crizotinib against existing treatments. Results of the early testing were given at a cancer conference in Chicago Saturday.
New Delhi: Congress on Saturday dismissed reports
that senior leader Pranab Mukherjee has quit as West Bengal
PCC chief after the party`s poor showing in the civic polls.
"Pranabda is one of the senior most leaders of the party.
Please do not speculate. He is the PCC chief even today and it
is not appropriate to make any comment", said party spokesman
Singhvi was asked by reporters to comment on reports that
Mukherjee, who is currently abroad, had met Gandhi after the
results of the civic polls were out and offered to quit owning